12162 related articles for article (PubMed ID: 10850348)
1. Comparison of the effects of Viscum album lectin ML-1 and fresh plant extract (Isorel) on the cell growth in vitro and tumorigenicity of melanoma B16F10.
Zarković N; Kalisnik T; Loncarić I; Borović S; Mang S; Kissel D; Konitzer M; Jurin M; Grainza S
Cancer Biother Radiopharm; 1998 Apr; 13(2):121-31. PubMed ID: 10850348
[TBL] [Abstract][Full Text] [Related]
2. An overview on anticancer activities of the Viscum album extract Isorel.
Zarkovic N; Vukovic T; Loncaric I; Miletic M; Zarkovic K; Borovic S; Cipak A; Sabolovic S; Konitzer M; Mang S
Cancer Biother Radiopharm; 2001 Feb; 16(1):55-62. PubMed ID: 11279798
[TBL] [Abstract][Full Text] [Related]
3. The Viscum album preparation Isorel inhibits the growth of melanoma B16F10 by influencing the tumour-host relationship.
Zarkovic N; Zarkovic K; Grainca S; Kissel D; Jurin M
Anticancer Drugs; 1997 Apr; 8 Suppl 1():S17-22. PubMed ID: 9179362
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic effects of the components in heat-treated mistletoe (Viscum album).
Park JH; Hyun CK; Shin HK
Cancer Lett; 1999 May; 139(2):207-13. PubMed ID: 10395180
[TBL] [Abstract][Full Text] [Related]
5. Mistletoe (viscum album) lectins as cytokine inducers and immunoadjuvant in tumor therapy. A review.
Bocci V
J Biol Regul Homeost Agents; 1993; 7(1):1-6. PubMed ID: 8346712
[TBL] [Abstract][Full Text] [Related]
6. Induction of apoptosis in human lymphocytes treated with Viscum album L. is mediated by the mistletoe lectins.
Büssing A; Suzart K; Bergmann J; Pfüller U; Schietzel M; Schweizer K
Cancer Lett; 1996 Jan; 99(1):59-72. PubMed ID: 8564930
[TBL] [Abstract][Full Text] [Related]
7. [Ingredients of mistletoe (Viscum album L.) as potential drugs].
Franz H
Pharmazie; 1985 Feb; 40(2):97-104. PubMed ID: 3889937
[No Abstract] [Full Text] [Related]
8. [Mistletoe therapy from the pharmacologic perspective].
Hajto T; Hostanska K; Saller R
Forsch Komplementarmed; 1999 Aug; 6(4):186-94. PubMed ID: 10529578
[TBL] [Abstract][Full Text] [Related]
9. Antiproliferative potential from aqueous Viscum album L. preparations and their main constituents in comparison with ricin and purothionin on human cancer cells.
Felenda JE; Turek C; Stintzing FC
J Ethnopharmacol; 2019 May; 236():100-107. PubMed ID: 30840914
[TBL] [Abstract][Full Text] [Related]
10. Polysaccharides from fresh Viscum album L. berry extract and their interaction with Viscum album agglutinin I.
Edlund U; Hensel A; Fröse D; Pfüller U; Scheffler A
Arzneimittelforschung; 2000 Jul; 50(7):645-51. PubMed ID: 10965423
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of biologically active lectin from Korean mistletoe, Viscum album var. Coloratum.
Lee HS; Kim YS; Kim SB; Choi BE; Woo BH; Lee KC
Cell Mol Life Sci; 1999 Apr; 55(4):679-82. PubMed ID: 10357236
[TBL] [Abstract][Full Text] [Related]
12. Effects of a standardized mistletoe preparation on metastatic B16 melanoma colonization in murine lungs.
Weber K; Mengs U; Schwarz T; Hajto T; Hostanska K; Allen TR; Weyhenmeyer R; Lentzen H
Arzneimittelforschung; 1998 May; 48(5):497-502. PubMed ID: 9638318
[TBL] [Abstract][Full Text] [Related]
13. Modulation of cytotoxicity and enhancement of cytokine release induced by Viscum album L. extracts or mistletoe lectins.
Ribéreau-Gayon G; Jung ML; Frantz M; Anton R
Anticancer Drugs; 1997 Apr; 8 Suppl 1():S3-8. PubMed ID: 9179359
[TBL] [Abstract][Full Text] [Related]
14. Viscum album L. preparation Isorel modifies the immune response in normal and in tumour-bearing mice.
Jurin M; Zarkovic N; Borovic S; Kissel D
Anticancer Drugs; 1997 Apr; 8 Suppl 1():S27-31. PubMed ID: 9179364
[TBL] [Abstract][Full Text] [Related]
15. Anti-mistletoe lectin antibodies are produced in patients during therapy with an aqueous mistletoe extract derived from Viscum album L. and neutralize lectin-induced cytotoxicity in vitro.
Stettin A; Schultze JL; Stechemesser E; Berg PA
Klin Wochenschr; 1990 Sep; 68(18):896-900. PubMed ID: 2124308
[TBL] [Abstract][Full Text] [Related]
16. Characterization of cytotoxic proteins from mistletoe (Viscum album L.).
Jung ML; Baudino S; Ribéreau-Gayon G; Beck JP
Cancer Lett; 1990 May; 51(2):103-8. PubMed ID: 2344587
[TBL] [Abstract][Full Text] [Related]
17. [Vysorel/Isorel--cancer drug from Viscum album. Documentation No.20].
Kast A; Hauser SP
Schweiz Rundsch Med Prax; 1990 Mar; 79(11):332-4. PubMed ID: 2315589
[TBL] [Abstract][Full Text] [Related]
18. Long-term administration of galactoside-specific mistletoe lectin in an animal model: no protection against N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats and no induction of a relevant local cellular immune response.
Kunze E; Schulz H; Adamek M; Gabius HJ
J Cancer Res Clin Oncol; 2000 Mar; 126(3):125-38. PubMed ID: 10741906
[TBL] [Abstract][Full Text] [Related]
19. Antitumorous and immunomodulatory effects of the Viscum album L. preparation Isorel.
Jurin M; Zarković N; Hrzenjak M; Ilić Z
Oncology; 1993; 50(6):393-8. PubMed ID: 8233280
[TBL] [Abstract][Full Text] [Related]
20. Isolation and partial characterization of a small chitin-binding lectin from mistletoe (Viscum album).
Peumans WJ; Verhaert P; Pfüller U; Van Damme EJ
FEBS Lett; 1996 Nov; 396(2-3):261-5. PubMed ID: 8914999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
